% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Zheng:141422,
author = {J.-S. Zheng and F. Imamura and S. J. Sharp and Y. T. van
der Schouw and I. Sluijs and T. E. Gundersen and E. Ardanaz
and H. Boeing and C. Bonet and J. H. Gómez and C. Dow and
G. Fagherazzi and P. W. Franks and M. Jenab and T. Kühn$^*$
and R. Kaaks$^*$ and T. J. Key and K.-T. Khaw and C.
Lasheras and O. Mokoroa and F. R. Mancini and P. M. Nilsson
and K. Overvad and S. Panico and D. Palli and O. Rolandsson
and S. Sieri and E. Salamanca-Fernández and C. Sacerdote
and A. M. Spijkerman and M. Stepien and A. Tjonneland and R.
Tumino and A. S. Butterworth and E. Riboli and J. Danesh and
C. Langenberg and N. G. Forouhi and N. J. Wareham},
title = {{A}ssociation of plasma vitamin {D} metabolites with
incident type 2 diabetes: {EPIC}-{I}nter{A}ct case-cohort
study.},
journal = {The journal of clinical endocrinology $\&$ metabolism},
volume = {104},
number = {4},
issn = {1945-7197},
address = {Oxford},
publisher = {Oxford University Press},
reportid = {DKFZ-2018-01928},
pages = {1293-1303},
year = {2019},
abstract = {Existing evidence for the prospective association of
vitamin D status with type 2 diabetes (T2D) is focused
almost exclusively on circulating total 25-hydroxyvitamin D
[25(OH)D] without distinction between its subtypes:
non-epimeric and epimeric 25(OH)D3 stereoisomers; and
25(OH)D2, the minor component of 25(OH)D. We aimed to
investigate the prospective associations of circulating
levels of the sum and each of these three metabolites with
incident T2D.This analysis in the EPIC-InterAct case-cohort
study for T2D included 9671 incident T2D cases and 13562
subcohort members. Plasma vitamin D metabolites were
quantified by liquid-chromatography mass-spectrometry. We
used multivariable Prentice-weighted Cox regression to
estimate hazard ratios (HRs) of T2D for each metabolite.
Analyses were performed separately within country, and
estimates combined across countries using random-effects
meta-analysis.The mean concentrations (standard deviation)
of total 25(OH)D, non-epimeric 25(OH)D3, epimeric 25(OH)D3
and 25(OH)D2 were 41.1 (17.2), 40.7 (17.3), 2.13 (1.31), and
8.16 (6.52) nmol/L, respectively. Plasma total 25(OH)D and
non-epimeric 25(OH)D3 were inversely associated with
incident T2D [multivariable-adjusted HR per 1-SD=0.81
$(95\%CI:$ 0.77, 0.86) for both variables], while epimeric
25(OH)D3 was positively associated: per 1-SD HR=1.16 (1.09,
1.25). There was no statistically significant association
with T2D for 25(OH)D2 [per 1-SD HR=0.94 (0.76, 1.18)].Plasma
non-epimeric 25(OH)D3 was inversely associated with incident
T2D, consistent with it being the major metabolite
contributing to total 25(OH)D. The positive association of
the epimeric form of 25(OH)D3 with incident T2D provides
novel information to assess the biological relevance of
vitamin D epimerization and vitamin D subtypes in diabetes
etiology.},
cin = {C020},
ddc = {610},
cid = {I:(DE-He78)C020-20160331},
pnm = {323 - Metabolic Dysfunction as Risk Factor (POF3-323)},
pid = {G:(DE-HGF)POF3-323},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:30418614},
doi = {10.1210/jc.2018-01522},
url = {https://inrepo02.dkfz.de/record/141422},
}